Treating COVID 19 using Micro RNA
Contenu principal de l'article
Résumé
Over 7,805,583 people worldwide are susceptible to death because of infection by an encountered microscopic virus known as Coronavirus. Actually, it is a family of infectious viruses that was first discovered for about 50 years by a group of virologists.
By time, COVID-19 has developed and adapted to the surrounding spread prohibitions.
That resulted in an incredible increase in the rate of death, in particular for old people who are suffering from other diseases and have frailty in their immunity that permit viruses attacks.
Various dense research is under working, as a way to uncover a cure or a vaccine on the long term. Hence, this paper focuses the lights on treating COVID-19 using a brand-new method of non-coding RNA (ncRNA).
Téléchargements
Renseignements sur l'article
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale 4.0 International.
A- Open Access statement and license:
1-Open Access statement:
JFMO provides immediate open access to published content in support of the idea that free access to research helps support the dissemination of knowledge and ideas in the field of medical science. All articles will be published under Creative Commons licenses.
All published data is immediate free access to the work and permits any user to read, download, copy, distribute print, search, or link to the full texts of articles.
The users of any published material in the JFMO must act in accordance with the Creative Commons Licenses CC BY-NC-ND 4.0.
2-License:
All published data is distributed following the Creative Commons Licenses CC BY-NC-ND 4.0. This license is allowing others to download the works and share them with others as long as they correctly cite the manuscript, No changes are allowed to the original manuscript and the manuscript must be used only for non for profit or non-commercial purposes.
This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License.
3-Self Archiving:
Authors are permitted and encouraged to share online their articles published in JFMO (e.g., in institutional repositories or on their website), as it can lead to productive exchanges, as well as earlier and greater citation of published work.
